Show simple item record

dc.contributor.authorBridgeman, VLen_US
dc.contributor.authorWan, Een_US
dc.contributor.authorFoo, Sen_US
dc.contributor.authorNathan, MRen_US
dc.contributor.authorWelti, JCen_US
dc.contributor.authorFrentzas, Sen_US
dc.contributor.authorVermeulen, PBen_US
dc.contributor.authorPreece, Nen_US
dc.contributor.authorSpringer, CJen_US
dc.contributor.authorPowles, Ten_US
dc.contributor.authorNathan, PDen_US
dc.contributor.authorLarkin, Jen_US
dc.contributor.authorGore, Men_US
dc.contributor.authorVasudev, NSen_US
dc.contributor.authorReynolds, ARen_US
dc.date.accessioned2016-02-02T16:29:48Z
dc.date.available2015-09-17en_US
dc.date.issued2016-01en_US
dc.date.submitted2016-01-13T14:28:07.016Z
dc.identifier.issn1535-7163en_US
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/11020
dc.description.sponsorshipThis work was supported by Breakthrough Breast Cancer (recently merged with Breast Cancer Campaign forming Breast Cancer Now) and by NHS funding to the NIHR Biomedical Research Centre at The Royal Marsden/Institute of Cancer Research.en_US
dc.format.extent172 - 183en_US
dc.relation.ispartofMOLECULAR CANCER THERAPEUTICSen_US
dc.rights• “The final publication is available at http://mct.aacrjournals.org/content/15/1/172.long”
dc.titlePreclinical Evidence That Trametinib Enhances the Response to Antiangiogenic Tyrosine Kinase Inhibitors in Renal Cell Carcinomaen_US
dc.typeArticle
dc.identifier.doi10.1158/1535-7163.MCT-15-0170en_US
pubs.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000372010200017&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.issue1en_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume15en_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record